Medicare Benefits Schedule - Item 50200

Search Results for Item 50200

View Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

50200

50200 - Additional Information

Item Start Date:
01-Dec-1991
Description Updated:
01-Jul-2021
Schedule Fee Updated:
01-Nov-2023

Group
T8 - Surgical Operations
Subgroup
15 - Orthopaedic
Subheading
16 - Malignant Disease

Core needle biopsy of aggressive or potentially malignant bone or soft tissue tumour, excluding aftercare  

Multiple Operation Rule

(Anaes.)

Fee: $207.15 Benefit: 75% = $155.40 85% = $176.10

(See para TN.8.209 of explanatory notes to this Category)


Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

TN.8.209

Procedure for diagnostic biopsy of bone tumor (Items 50200 and 50201)

  • Histological proof of either the benign, the aggressive benign, or the malignant nature of the process should be obtained.
  • Histological proof may be obtained in conjunction with items 50203, 50206 or 50209. It may be obtained at the time of the procedure (e.g. by intraoperative frozen section analysis of the tumour tissue).

Related Items: 50200 50201 50203 50206 50209


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change